Cvs Health (CVS) Shares Outstanding (Weighted Average) (2009 - 2026)

Cvs Health (CVS) has 18 years of Shares Outstanding (Weighted Average) data on file, last reported at $1.3 billion in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 0.95% year-over-year to $1.3 billion; the trailing twelve-month figure through Mar 2026 stood at $1.3 billion (up 0.95% YoY), and the FY2025 full-year result was $1.3 billion, up 0.64% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $1.3 billion, roughly flat from $1.3 billion in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $1.3 billion in Q3 2022 and bottomed at $1.3 billion in Q2 2024.
• The 5-year median for Shares Outstanding (Weighted Average) is $1.3 billion (2026), against an average of $1.3 billion.
• The widest annual swing landed in 2024, when Shares Outstanding (Weighted Average) decreased 2.25%; it then climbed 0.95% in 2026.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $1.3 billion in 2022, then dropped by 2.06% to $1.3 billion in 2023, then fell by 2.02% to $1.3 billion in 2024, then rose by 0.64% to $1.3 billion in 2025, then gained by 0.47% to $1.3 billion in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $1.3 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.

Peer Comparison